These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 6176229)

  • 1. Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.
    Silverman RH
    J Virol; 2007 Dec; 81(23):12720-9. PubMed ID: 17804500
    [No Abstract]   [Full Text] [Related]  

  • 2. A scientific journey through the 2-5A/RNase L system.
    Silverman RH
    Cytokine Growth Factor Rev; 2007; 18(5-6):381-8. PubMed ID: 17681844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theiler's virus strain-dependent induction of innate immune responses in RAW264.7 macrophages and its influence on viral clearance versus viral persistence.
    Steurbaut S; Rombaut B; Vrijsen R
    J Neurovirol; 2007; 13(1):47-55. PubMed ID: 17454448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of the double-stranded RNA-binding core protein sigmaA in the resistance of avian reovirus to interferon.
    Martínez-Costas J; González-López C; Vakharia VN; Benavente J
    J Virol; 2000 Feb; 74(3):1124-31. PubMed ID: 10627522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.
    Player MR; Torrence PF
    Pharmacol Ther; 1998 May; 78(2):55-113. PubMed ID: 9623881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection.
    Li XL; Blackford JA; Hassel BA
    J Virol; 1998 Apr; 72(4):2752-9. PubMed ID: 9525594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L.
    Zhou A; Paranjape J; Brown TL; Nie H; Naik S; Dong B; Chang A; Trapp B; Fairchild R; Colmenares C; Silverman RH
    EMBO J; 1997 Nov; 16(21):6355-63. PubMed ID: 9351818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brefeldin A inhibits the antiviral action of interferon against encephalomyocarditis virus.
    Sidhu GS; Singh AK; Raghunath PN; Sivaram S; Maheshwari RK
    Virus Res; 1996 Feb; 40(2):123-33. PubMed ID: 8725108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of ppp(A2'p)nA-dependent RNase in murine JLS-V9R cells during growth inhibition.
    Jacobsen H; Krause D; Friedman RM; Silverman RH
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):4954-8. PubMed ID: 6576368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication.
    Rice AP; Roberts WK; Kerr IM
    J Virol; 1984 Apr; 50(1):220-8. PubMed ID: 6422053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction and maintenance of 2',5'-oligoadenylate synthetase in interferon-treated chicken embryo cells.
    West DK; Ball LA
    Mol Cell Biol; 1982 Nov; 2(11):1436-43. PubMed ID: 6186904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA.
    SenGupta DN; Silverman RH
    Nucleic Acids Res; 1989 Feb; 17(3):969-78. PubMed ID: 2922280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of ppp(A2'p)nA-dependent RNase by a temperature-sensitive mutant of vaccinia virus.
    Cohrs RJ; Condit RC; Pacha RF; Thompson CL; Sharma OK
    J Virol; 1989 Feb; 63(2):948-51. PubMed ID: 2911126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the role of the 2'-5'-oligoadenylate synthetase-RNase L pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication.
    Kumar R; Choubey D; Lengyel P; Sen GC
    J Virol; 1988 Sep; 62(9):3175-81. PubMed ID: 2841470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation by levamisole, methisoprinol, and adenine or adenosine of the inhibitory activity of human interferon against encephalomyocarditis virus.
    Muñoz A; García RA; Pérez-Aranda A
    Antimicrob Agents Chemother; 1986 Jul; 30(1):192-5. PubMed ID: 2428301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-mediated inhibition of the ppp(A2'p)nA system and its prevention by interferon.
    Cayley PJ; Knight M; Kerr IM
    Biochem Biophys Res Commun; 1982 Jan; 104(2):376-82. PubMed ID: 6176229
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of the ppp(a2'p)nA system in HeLa cells. Effects of interferon and virus infection.
    Silverman RH; Cayley PJ; Knight M; Gilbert CS; Kerr IM
    Eur J Biochem; 1982 May; 124(1):131-8. PubMed ID: 6177533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the ppp(A2'p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNase.
    Cayley PJ; Davies JA; McCullagh KG; Kerr IM
    Eur J Biochem; 1984 Aug; 143(1):165-74. PubMed ID: 6088228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells.
    Wreschner DH; James TC; Silverman RH; Kerr IM
    Nucleic Acids Res; 1981 Apr; 9(7):1571-81. PubMed ID: 6164990
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.